Lv4
634 积分 2024-05-13 加入
Management of relapsed/refractory mantle cell lymphoma
2天前
已完结
SOHO State of the Art Updates and Next Questions: Treatment Evolution of Mantle Cell Lymphoma: Navigating the Different Entities and Biological Heterogeneity of Mantle Cell Lymphoma in 2024
2天前
已完结
Mantle cell lymphoma: what clinical progress in the last 5 years?
2天前
已完结
Mantle cell lymphoma
2天前
已关闭
Tumor Lysis Syndrome
3天前
已完结
Expert consensus guidelines for the prophylaxis and management of tumor lysis syndrome in the United States: Results of a modified Delphi panel
6天前
已完结
Converging paths toward unified therapeutic approaches in atopic dermatitis, vitiligo, and alopecia areata
6天前
已完结
Vitiligo
6天前
已完结
The Value of no Evidence of Disease (NED) in Intermediate‐Stage Hepatocellular Carcinoma After TACE: A Real‐World Study
10天前
已完结
Adjuvant lenvatinib in combination with transarterial chemoembolization for hepatocellular carcinoma patients with high risk of postoperative recurrence: A multicenter prospective cohort study
10天前
已完结
皖公网安备34019202002308
